SEC Form 4 research
| Issuer | Ascendis Pharma A/S |
|---|---|
| Tickers | ASND |
| Reporting owners | 15 |
| Officers and directors | 4 |
| Last public filing | 2026-09-28 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-28 | 2026-04-14 | BIENAIME JEAN JACQUES | A | 9,160 | Not reported | Not reported |
| 2026-09-09 | 2026-09-08 | Bodenhoff Mads | S | 3,000 | $270.19 | Not reported |
| 2026-09-03 | 2026-09-02 | HOLTUG LARS | S | 236 | $264.13 | Not reported |
| 2026-08-18 | 2026-08-14 | BIENAIME JEAN JACQUES | P | 900 | $246.91 | Not reported |
| 2026-08-18 | 2026-08-14 | BIENAIME JEAN JACQUES | P | 1,100 | $245.85 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.